Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 31 Aug, 01:30 am
Rubrik's Q2 Earnings Exceed Expectations: The cybersecurity firm reported an impressive earnings per share (EPS) of $0.20 , significantly surpassing analyst estimates of $0.04 and marking a strong turnaround from a prior-year loss. Robust Revenue Growth Driven by Subscriptions: R
Petrobras (NYSE: PBR) has delivered exceptional year-to-date stock performance, significantly outperforming major oil competitors. Analysts have upgraded the stock to an "Outperform" rating, setting a price target that suggests a notable upside for investors. The company's strong
Financial Headwinds : JinkoSolar reported a significant 31% decrease in Q2 revenue to $1.82 billion and a sharp decline in gross margin to 4.2% , leading to its stock hitting a new 52-week low of $13.04 . Analyst Outlook : Investment firm Roth Capital maintained a "Neutral" inves
Elastic reported robust Q1 fiscal 2027 earnings, with an EPS of $0.70 , significantly surpassing analyst expectations. The company achieved impressive revenue growth, reaching $478.11 million , driven by a 15% increase in total subscription revenue and the addition of over 80 new
Earnings Beat: Gap Inc. (NYSE: GAP) reported adjusted EPS of $0.52 , exceeding analyst estimates of approximately $0.48–$0.50 . Revenue Miss and Brand Weakness: Quarterly revenue declined 2% to $3.65 billion , below the approximately $3.69 billion consensus estimate, as wea
The Metals Company is advancing its unique deep-sea mining operations, focusing on polymetallic nodules essential for EV battery and clean energy technologies . Analyst firm Stifel Nicolaus initiated coverage with a "Buy" rating and a $10.00 price target, indicating a potential 9
Victory Capital Holdings (NASDAQ: VCTR) is set to acquire First Eagle Investments for approximately $7.00 billion , significantly expanding its client assets to around $571.00 billion . The asset management firm has demonstrated robust stock performance , hitting a new 52-week hi
Analyzing Best Buy (NYSE: BBY): Strong Q2 Results and Raised Guidance Truist Securities analyst Scot Ciccarelli raised his price target for Best Buy Co., Inc. (NYSE: BBY) to $100 from $95 , maintaining a Buy rating. Fiscal Q2 2027 revenue increased 3.6% to $9.78 billion , while c
BP's Market Position & Valuation: A major global energy company with a significant market capitalization of approximately $111.04 billion , currently trading at $42.34 per share . Conflicting Analyst Ratings: While Deutsche Bank (NYSE: DB) downgraded BP to "Hold," Zacks Investmen
Top Stock Losers: Corporate Developments and Leveraged ETFs Drive Sharp Declines Company-Specific Catalysts: New equity offerings, reduced financial guidance, and fading takeover expectations triggered immediate and significant stock-price reactions. Rapid Sentiment Shifts: Inves
Market Movers: Leveraged ETFs and Identity Security Stocks Drive Significant Gains Okta’s Strong Performance: Identity security company Okta, Inc. (NASDAQ: OKTA) surged more than 28% after exceeding fiscal second-quarter 2027 estimates and raising its full-year outlook, boo
Strong Earnings Beat: Pernod Ricard's earnings per share (EPS) and revenue for Q4 2026 surpassed analyst expectations. Challenging Sales Environment: Despite the beat, the company faces significant organic sales declines in key markets like the U.S. and China, driven by weak cons
BYD Company Limited (OTC:BYDDY) is poised for strong Q2 earnings driven by robust EV sales and export momentum . The company demonstrates competitive strength, surpassing Tesla (NASDAQ: TSLA) in gross profit margins and delivery volume . Strategic expansion into overseas markets
Recent stock performance shows short-term volatility with a 5.66% gain over the past month but an 11.70% loss in the last 10 days. Analysts project a significant 21.55% growth potential, with a target price of $311.33 , indicating a potential upside for the stock. The company dem
Strong Stock Momentum: Diodes Incorporated's stock surged 19.27% in 30 days, indicating positive market movement. Potential Entry Point: A recent 12.30% decline in 10 days brings the stock to a local minimum, potentially attracting investors. Robust Financials & High Target Price
Alterity Therapeutics Limited is actively developing experimental therapies, ATH434 and PBT2, for neurological disorders like Parkinson's and Alzheimer's disease. The consensus analyst price target for the company has remained stable at $8.67 , though some experts, such as Adam V
Canadian Solar (NASDAQ: CSIQ) Faces Headwinds Following Mixed Q2 Results and Lower Price Target Citigroup maintained its “ Neutral ” rating on Canadian Solar but lowered its price target to $15 from $18 . Canadian Solar reported a GAAP net loss of $1.40 per share , wi
Bilibili (NASDAQ: BILI) Q2 2026 Earnings: Profitability Expands Amid Strong User Engagement Bilibili (NASDAQ: BILI) reported adjusted diluted EPS of $0.23 per ADS , matching the Zacks consensus estimate, while revenue of $1.17 billion exceeded the Zacks estimate by 0.40%. Gross p
Headlines provided by Investing.com